Overview Dividends

(PM) Philip Morris International - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7181721090

Cigarettes, Heat-Not-Burn, Vapor, Oral Nicotine, Wellness

Tobacco
Market Cap in USD: 244,143m

IPO / Inception: 2008-03-17
Return 12m vs S&P 500: 18.2%

EPS (Earnings per Share)

EPS CAGR: 14.46%
EPS Trend: 71.3%

Last SUE: 2.38
Qual. Beats: 1

Revenue

Rev. CAGR: 8.08%
Rev. Trend: 93.2%

Last SUE: 1.05
Qual. Beats: 1

Dividends

Dividend Yield	3.39%
Yield on Cost 5y	8.45%
Yield CAGR 5y	2.83%
Payout Consistency	99.1%
Payout Ratio	76.3%

Risk via 5d forecast
Volatility	23.2%
Value at Risk 5%th	36.5%
Relative Tail Risk	-4.49%

Reward TTM
Sharpe Ratio	1.15
Alpha	30.40
CAGR/Max DD	1.09

Character TTM
Hurst Exponent	0.434
Beta	0.087
Beta Downside	0.260

Drawdowns 3y
Max DD	20.64%
Mean DD	5.90%
Median DD	5.51%

Description: PM Philip Morris International December 02, 2025

Philip Morris International Inc. (PM) is a global tobacco firm that sells traditional cigarettes and a growing portfolio of smoke-free products-including heat-not-burn IQOS, vapor devices, and oral nicotine ZYN-alongside consumer accessories and emerging wellness offerings. The company, incorporated in 1987, is headquartered in Stamford, Connecticut.

Key metrics highlight the transition to reduced-risk products: FY 2023 net revenue reached roughly $29.5 billion, with smoke-free offerings accounting for about 20 % of total sales and posting double-digit growth year-over-year. IQOS holds an estimated 30 % market share in Japan, the world’s largest reduced-risk market, while ZYN has become the leading oral nicotine brand in the United States, driving a ~15 % increase in U.S. revenue. The sector faces headwinds from declining smoking prevalence and tightening regulations, but the shift toward nicotine-delivery alternatives is a primary growth catalyst.

For a deeper quantitative dive into PM’s valuation dynamics, the ValueRay platform offers a concise, data-driven dashboard worth checking out.

Piotroski VR‑10 (Strict, 0-10) 7.0

Net Income (8.61b TTM) > 0 and > 6% of Revenue (6% = 2.40b TTM)

FCFTA 0.15 (>2.0%) and ΔFCFTA 0.09pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -10.15% (prev -6.91%; Δ -3.25pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.17 (>3.0%) and CFO 11.53b > Net Income 8.61b (YES >=105%, WARN >=100%)

Net Debt (46.05b) to EBITDA (17.68b) ratio: 2.60 <= 3.0 (WARN <= 3.5)

Current Ratio 0.85 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (1.56b) change vs 12m ago 0.13% (target <= -2.0% for YES)

Gross Margin 66.27% (prev 64.18%; Δ 2.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 59.63% (prev 55.64%; Δ 3.99pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 8.18 (EBITDA TTM 17.68b / Interest Expense TTM 1.92b) >= 6 (WARN >= 3)

Altman Z'' 3.19

(A) -0.06 = (Total Current Assets 22.66b - Total Current Liabilities 26.72b) / Total Assets 67.06b

(B) 0.53 = Retained Earnings (Balance) 35.56b / Total Assets 67.06b

(D) 0.27 = Book Value of Equity 20.68b / Total Liabilities 76.05b

Total Rating: 3.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 76.99

1. Piotroski 7.0pt

2. FCF Yield 3.49%

3. FCF Margin 25.35%

4. Debt/Equity -4.59

5. Debt/Ebitda 2.60

6. ROIC - WACC (= 29.02)%

7. RoE -75.66%

8. Rev. Trend 93.19%

9. EPS Trend 71.25%

What is the price of PM shares?

As of December 25, 2025, the stock is trading at USD 162.64 with a total of 1,754,444 shares traded.
Over the past week, the price has changed by +2.54%, over one month by +7.67%, over three months by +0.72% and over the past year by +37.27%.

Is PM a buy, sell or hold?

Philip Morris International has received a consensus analysts rating of 4.06. Therefore, it is recommended to buy PM.

Strong Buy: 7
Buy: 5
Hold: 4
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the PM price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	182.9	12.4%
Analysts Target Price	182.9	12.4%
ValueRay Target Price	198.3	21.9%

PM Fundamental Data Overview December 22, 2025

Market Cap USD = 244.14b (244.14b USD * 1.0 USD.USD)
P/E Trailing = 22.3738
P/E Forward = 18.7266
P/S = 6.1048
P/EG = 1.0233
Beta = 0.436
Revenue TTM = 39.94b USD
EBIT TTM = 15.69b USD
EBITDA TTM = 17.68b USD
Long Term Debt = 41.86b USD (from longTermDebt, last quarter)
Short Term Debt = 8.22b USD (from shortTermDebt, last quarter)
Debt = 50.08b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 46.05b USD (from netDebt column, last quarter)
Enterprise Value = 290.19b USD (244.14b + Debt 50.08b - CCE 4.04b)
Interest Coverage Ratio = 8.18 (Ebit TTM 15.69b / Interest Expense TTM 1.92b)
FCF Yield = 3.49% (FCF TTM 10.12b / Enterprise Value 290.19b)
FCF Margin = 25.35% (FCF TTM 10.12b / Revenue TTM 39.94b)
Net Margin = 21.56% (Net Income TTM 8.61b / Revenue TTM 39.94b)
Gross Margin = 66.27% ((Revenue TTM 39.94b - Cost of Revenue TTM 13.47b) / Revenue TTM)
Gross Margin QoQ = 67.85% (prev 67.66%)
Tobins Q-Ratio = 4.33 (Enterprise Value 290.19b / Total Assets 67.06b)
Interest Expense / Debt = 0.46% (Interest Expense 230.0m / Debt 50.08b)
Taxrate = 17.21% (751.0m / 4.36b)
NOPAT = 12.99b (EBIT 15.69b * (1 - 17.21%))
Current Ratio = 0.85 (Total Current Assets 22.66b / Total Current Liabilities 26.72b)
Debt / Equity = -4.59 (negative equity) (Debt 50.08b / totalStockholderEquity, last quarter -10.91b)
Debt / EBITDA = 2.60 (Net Debt 46.05b / EBITDA 17.68b)
Debt / FCF = 4.55 (Net Debt 46.05b / FCF TTM 10.12b)
Total Stockholder Equity = -11.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.84% (Net Income 8.61b / Total Assets 67.06b)
RoE = -75.66% (negative equity) (Net Income TTM 8.61b / Total Stockholder Equity -11.38b)
RoCE = 51.48% (EBIT 15.69b / Capital Employed (Equity -11.38b + L.T.Debt 41.86b))
RoIC = 34.35% (NOPAT 12.99b / Invested Capital 37.82b)
WACC = 5.33% (E(244.14b)/V(294.23b) * Re(6.34%) + D(50.08b)/V(294.23b) * Rd(0.46%) * (1-Tc(0.17)))
Discount Rate = 6.34% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.13%
[DCF Debug] Terminal Value 77.70% ; FCFE base≈10.09b ; Y1≈9.70b ; Y5≈9.51b
Fair Price DCF = 108.9 (DCF Value 169.53b / Shares Outstanding 1.56b; 5y FCF grow -5.18% → 3.0% )
EPS Correlation: 71.25 | EPS CAGR: 14.46% | SUE: 2.38 | # QB: 1
Revenue Correlation: 93.19 | Revenue CAGR: 8.08% | SUE: 1.05 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.90 | Chg30d=-0.003 | Revisions Net=-1 | Analysts=7
EPS next Year (2026-12-31): EPS=8.34 | Chg30d=-0.005 | Revisions Net=-2 | Growth EPS=+10.6% | Growth Revenue=+7.7%

Additional Sources for PM Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle